Drug Development Solutions

  1. Inhaled Product Development 3/3/2022

    Our integrated capabilities and vast knowledge encompasses pre-formulation sciences, formulation development, device evaluation, clinical trial manufacturing and the clinical assessment of a variety of inhaled formats for nasal and pulmonary delivery.

  2. Surfactant Analysis Services

    Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.

  3. Antibody Drug Conjugates: Link Your Antibody To Its Fullest Potential

    Learn how our parallel development service works seamlessly with our existing antibody capabilities, helping to accelerate your ADC program and reach market faster.

  4. Resin Offering High Productivity And Robust Processes 5/3/2023

    MabSelect™ VL affinity resin uses a protein L ligand with strong affinity for the variable region of a human antibody’s kappa light chain. The resin offers high productivity and robust processes for affinity capture of bispecific antibodies and antibody fragments containing the kappa light chain and offers a good capture alternative for antibody variants that does not bind to protein A.

  5. Advanced Linker Payload Solutions 7/11/2024

    Our expertise with mAbs and linker technologies ensures the development of ADCs that are not only effective and safe but also tailored to address the specific challenges of targeted therapies.

  6. Analytical Development And Characterization For mRNA 7/11/2023

    Meet your mRNA product's specific needs with assay packages that provide the product and process knowledge needed to develop a quality target product profile and identify critical quality attributes.

  7. End-to-End Services In Vaccines, CGTs, And Biologics 7/25/2023

    IDT Biologika provides end-to-end services in contract development and manufacturing of vaccines, cell and gene therapeutics, and fill/finish of biologics.

  8. Molecule To Cure. Fast.

    Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast.

  9. Ready To Meet Your Complex OSD Needs, Seamlessly And Simply

    Explore an approach that accelerates your project through key milestones with a technology transfer process that ensures a fast start and process analytical technology that increases efficiency and reduces cost.

  10. Analytical Labs Particle Analysis

    Particulate in a drug product represents a huge risk not only to patient safety – but also to a drug company’s reputation and bottom line. As concern about particulate rises, partnering with a particle analysis team enables customers to gain an intimate understanding of particle sources related to packaging and delivery systems.